|
RAN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.487000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.743400E-01 |
| Normal-vs-Stage2 |
3.952100E-02 |
| Normal-vs-Stage3 |
3.463200E-01 |
| Normal-vs-Stage4 |
2.347200E-01 |
| Stage1-vs-Stage2 |
9.184100E-02 |
| Stage1-vs-Stage3 |
6.686800E-01 |
| Stage1-vs-Stage4 |
4.823200E-01 |
| Stage2-vs-Stage3 |
2.229200E-01 |
| Stage2-vs-Stage4 |
3.903000E-01 |
| Stage3-vs-Stage4 |
7.401600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.633800E-01 |
| Normal-vs-AfricanAmerican |
8.111800E-01 |
| Normal-vs-Asian |
3.800400E-01 |
| Caucasian-vs-AfricanAmerican |
9.594400E-01 |
| Caucasian-vs-Asian |
4.979400E-01 |
| AfricanAmerican-vs-Asian |
6.569800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.354400E-02 |
| Normal-vs-Female |
4.139600E-01 |
| Male-vs-Female |
1.858960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.920600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.123900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.344000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.359400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.249160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.484000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.125600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.289600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.364800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.041400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.877800E-01 |
| Classical-VS-Follicular |
1.60277999999847E-05 |
| Classical-VS-Other |
4.340800E-01 |
| Classical-VS-Normal |
9.579000E-01 |
| Tall-VS-Follicular |
2.839800E-03 |
| Tall-VS-Other |
2.446200E-01 |
| Tall-VS-Normal |
5.793800E-01 |
| Follicular-VS-Other |
6.651400E-01 |
| Follicular-VS-Normal |
3.638800E-04 |
| Other-VS-Normal |
4.492200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.697800E-02 |
| Normal-vs-N1 |
2.884000E-02 |
| N0-vs-N1 |
3.049600E-01 |
|
|
